About Dr. Shen Tao
Biography
Dr. Shen Tao is a Master Supervisor, PhD in Oncology, and Postdoc in Med-Eng research. He has been dedicated to Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University) since 2004. He currently serves as the Vice Director of the Colorectal Surgery Department.
Professional Experience
With over 20 years of clinical and research experience, Dr. Shen has mastered the diagnosis and treatment of complex colorectal diseases. He is a pioneer in ERAS (Enhanced Recovery After Surgery), nutritional management, and fecal microbiota transplantation (FMT) in Yunnan.
Innovation Philosophy
"Never stuck in tradition; always an early adopter and explorer of new frontiers, such as AI in healthcare and collaborative R&D of medical devices."
Academic & Teaching
Master supervisor and lecturer for MBBS international students. Trainer for National Chronic Disease Management. Regularly awarded for excellence in teaching competitions.
Books & Expert Consensuses
Modern Diagnosis and Treatment of Colorectal Cancer (Chief Editor)
New Practical Clinical Oncology (Co-Chief Editor)
Chinese Expert Consensus on Multidisciplinary Treatment of Appendix Tumors 2021
Chinese Expert Consensus on NOSES for Benign Abdominal Diseases
Blue Book of Tumor Nutrition in China
Professional Societies
Chairman, Med-Eng Integration Committee, Yunnan Anti-Cancer Association
Vice Chairman, Enteral and Parenteral Nutrition Branch, Yunnan Medical Association
Vice Chairman, Tumor Nutrition Committee, Yunnan Anti-Cancer Association
Vice Chairman, Accelerated Recovery (ERAS) Committee, Yunnan Rehabilitation Medical Association
Vice Chairman, Med-Eng Life & Health Committee, Yunnan Computer Federation
Vice Chairman, Oncology Branch Youth Committee, Yunnan Medical Association
Council Member, World Endoscopy Physicians Association (WEO) Hepatobiliary & Gastrointestinal Alliance
Key Publications
A two-stage deep learning prediction system for colon cancer microsatellite instability status using CT images (Front. Oncol. 2026)
Neoadjuvant therapy with cadonilimab in a patient with MSI-H/dMMR colorectal cancer: a case report (Front. Oncol. 2026)
Machine learning-based radiomics approach assessing preoperative non-contrast CT for microsatellite instability prediction in colon cancer (Front. Physiol. 2025)
EAG-SAE-ESTF: An entropy-aware gated network with scale-adaptive enhancement and elastic spatial topology fusion for coronary artery segmentation (Info. Fusion 2026)
Enhancing diagnosis prediction with adaptive disease representation (Artif Intell Med. 2025)
Neoadjuvant envafolimab in MSI-H/dMMR colon cancer (Immunotherapy 2024)
Gut Microbiota Transplantation in MSS Colorectal Cancer (Cureus 2023)
Protein homeostasis in aging and cancer (Front Cell Dev Biol. 2023)
mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis (BMC Cancer 2022)
CXCL8 Up-Regulated LSECtin through AKT Signal and Correlates with the Immune Microenvironment Modulation in Colon Cancer (Cancers 2022)
Hypoxia-immune-related LncRNA signature for CRC (Front Immunol. 2022)